Literature DB >> 30326738

Erythema Nodosum Leprosum Triggered by Antecedent Influenza Vaccine and Respiratory Tract Infection: A Case Report.

Matthew K Sandre1,2, Sonia M Poenaru3, Andrea K Boggild2,4,5.   

Abstract

We present a patient with new-onset erythema nodosum leprosum months after successful treatment of her mid-borderline leprosy, which was likely triggered by a combination of antecedent influenza vaccination and upper respiratory tract infection.

Entities:  

Keywords:  Hansen disease; erythema nodosum leprosum

Mesh：

Substances：

Year:  2018        PMID： 30326738     DOI： 10.1177/1203475418808759

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN： 1203-4754            Impact factor:   2.092


  6 in total

Review 1.  Immune-mediated adverse reactions to vaccines.

Authors:  Cosby A Stone; Christine R F Rukasin; Thomas M Beachkofsky; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2019-11-05       Impact factor: 4.335

2.  Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.

Authors:  Jeffrey Craig; Cara MacRae; Rochelle G Melvin; Andrea K Boggild
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

Review 3.  A review of nutrition in neuropathic pain of leprosy.

Authors:  Michael Klowak; Andrea K Boggild
Journal:  Ther Adv Infect Dis       Date:  2022-06-01

4.  Effects of cefuroxime axetil combined with Xingpi Yanger granules on the serum gastrin, motilin, and somatostatin levels in children with upper respiratory tract infection accompanied by diarrhea: results of a randomized trial.

Authors:  Xiaohong Ren; Yuying Wang; Zimeng He; Hongli Liu; Kun Xue
Journal:  Transl Pediatr       Date:  2021-08

5.  Erythema nodosum leprosum post-COVID-19 vaccination: endemic while pandemic.

Authors:  T Fachler; K Olshtain-Pops; L Horev
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-08       Impact factor: 9.228

6.  Reactions in leprosy patients triggered by COVID-19 vaccination - a cross-sectional study from a tertiary care centre in India.

Authors:  A Bhandari; S Gupta; S Dogra; T Narang
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06-30       Impact factor: 9.228
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.